Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)

CompletedOBSERVATIONAL
Enrollment

712

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

December 27, 2024

Study Completion Date

December 27, 2024

Conditions
Lung Cancer, Biliary Tract Cancer
Trial Locations (24)

Unknown

Research Site, Changwon-si

Research Site, Chuncheon

Research Site, Hwasun-gun

Research Site, Iksan-si

Research Site, Jeju-do

Research Site, Jeonju

Research Site, Pohang-si

Research Site, Wŏnju

Research Site, Yangsan

Research Site, Anyang-si

Research Site, Bucheon-si

Research Site, Busan

Research Site, Changwon

Research Site, Cheonan

Research Site, Daegu

Research Site, Daejeon

Research Site, Goyang-si

Research Site, Gwangju

Research Site, Incheon

Research Site, Seongnam-si

Research Site, Seoul

Research Site, Suwon

Research Site, Uijeongbu-si

Research Site, Yongin-si

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY